CL2007003331A1 - Metodo para tratar cancer mediante la administracion de un agente radiosensibilizante derivado de benzo[a]trinden-4,6-diona; composicion farmaceutica que comprende dicho agente. - Google Patents

Metodo para tratar cancer mediante la administracion de un agente radiosensibilizante derivado de benzo[a]trinden-4,6-diona; composicion farmaceutica que comprende dicho agente.

Info

Publication number: CL2007003331A1
Authority: CL; Chile
Prior art keywords: agent; radiosensibilizing; trinden; diona; benzo
Prior art date: 2006-11-20

Application number

CL200703331A

Other languages

English (en)

Inventor

James L Hudkins Lobert Diebold

Original Assignee

Cephalon Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-11-20

Filing date

2007-11-20

Publication date

2008-07-04

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39259576&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2007003331(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-11-20 Application filed by Cephalon Inc filed Critical Cephalon Inc

2008-07-04 Publication of CL2007003331A1 publication Critical patent/CL2007003331A1/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

CL200703331A 2006-11-20 2007-11-20 Metodo para tratar cancer mediante la administracion de un agente radiosensibilizante derivado de benzo[a]trinden-4,6-diona; composicion farmaceutica que comprende dicho agente. CL2007003331A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US86003606P	2006-11-20	2006-11-20

Publications (1)

Publication Number	Publication Date
CL2007003331A1 true CL2007003331A1 (es)	2008-07-04

Family

ID=39259576

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL200703331A CL2007003331A1 (es)	2006-11-20	2007-11-20	Metodo para tratar cancer mediante la administracion de un agente radiosensibilizante derivado de benzo[a]trinden-4,6-diona; composicion farmaceutica que comprende dicho agente.

Country Status (18)

Country	Link
US (1)	US20080146556A1 (es)
EP (1)	EP2086525B1 (es)
JP (1)	JP5542444B2 (es)
CN (1)	CN101784268B (es)
AR (1)	AR063869A1 (es)
AT (1)	ATE483456T1 (es)
AU (1)	AU2007321987B2 (es)
CA (1)	CA2671517C (es)
CL (1)	CL2007003331A1 (es)
DE (1)	DE602007009717D1 (es)
ES (1)	ES2352817T3 (es)
HK (1)	HK1137347A1 (es)
IL (1)	IL198519A (es)
MX (1)	MX2009005292A (es)
NZ (2)	NZ595522A (es)
PT (1)	PT2086525E (es)
TW (2)	TWI519313B (es)
WO (1)	WO2008063644A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ598883A (en)	2009-08-26	2014-09-26	Cephalon Inc	Crystalline forms of a parp inhibitor compound
TWI482621B (zh)	2009-12-23	2015-05-01	Sigma Tau Ind Farmaceuti	青蒿素基藥物與其他化學治療劑的抗癌組合物
AR092790A1 (es)	2012-02-01	2015-05-06	Euro Celtique Sa	Derivados bencimidazolicos del acido hidroxamico
US9771325B2 (en)	2014-02-14	2017-09-26	Council Of Scientific & Industrial Research	Tricyclic compounds and preparation thereof
WO2015121876A1 (en) *	2014-02-14	2015-08-20	Council Of Scientific & Industrial Research	Novel tricyclic compounds and preparation thereof
GB201409488D0 (en)	2014-05-28	2014-07-09	Euro Celtique Sa	Pharmaceutical composition
GB201409471D0 (en)	2014-05-28	2014-07-09	Euro Celtique Sa	Pharmaceutical composition
GB201409485D0 (en)	2014-05-28	2014-07-09	Euro Celtique Sa	Pharmaceutical composition
US10150772B2 (en)	2014-11-26	2018-12-11	Cephalon, Inc.	Crystalline forms of PARP inhibitors
CN104961798A (zh) *	2015-06-28	2015-10-07	杨洋	作为parp抑制剂的化合物
WO2018068832A1 (en)	2016-10-11	2018-04-19	Euro-Celtique S.A.	Hodgkin lymphoma therapy
GB201709405D0 (en)	2017-06-13	2017-07-26	Euro Celtique Sa	Compounds for treating ovarian cancer
GB201709406D0 (en)	2017-06-13	2017-07-26	Euro-Cletique S A	Compounds for treating TNBC
GB201709402D0 (en)	2017-06-13	2017-07-26	Euro Celtique Sa	Compounds for treating t-pll
GB201709403D0 (en)	2017-06-13	2017-07-26	Euro Celtique Sa	Compounds for treating sarcoma
CN113952452A (zh) *	2021-11-16	2022-01-21	苏州伊瑞斯科技有限公司	一种基于碳点的肿瘤放疗增敏剂及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6635642B1 (en) *	1997-09-03	2003-10-21	Guilford Pharmaceuticals Inc.	PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
US6197785B1 (en) *	1997-09-03	2001-03-06	Guilford Pharmaceuticals Inc.	Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
WO1999059973A1 (en) *	1998-05-15	1999-11-25	Guilford Pharmaceuticals Inc.	Carboxamide compounds, compositions, and methods for inhibiting parp activity
US7122679B2 (en) *	2000-05-09	2006-10-17	Cephalon, Inc.	Multicyclic compounds and the use thereof
US20060276497A1 (en) *	2000-05-09	2006-12-07	Cephalon, Inc.	Novel multicyclic compounds and the use thereof
CN1568187A (zh) *	2001-08-15	2005-01-19	Icos股份有限公司	2h－2,3－二氮杂萘－1－酮和其使用方法
KR20070046183A (ko) *	2004-09-22	2007-05-02	화이자 인코포레이티드	폴리(에이디피-리보오스) 폴리머라제 저해제를 포함하는치료 배합물
US7728026B2 (en) *	2005-04-11	2010-06-01	Abbott Laboratories, Inc.	2-substituted-1 h-benzimidazile-4-carboxamides are PARP inhibitors

2007
- 2007-11-20 WO PCT/US2007/024271 patent/WO2008063644A1/en active Application Filing
- 2007-11-20 CA CA2671517A patent/CA2671517C/en not_active Expired - Fee Related
- 2007-11-20 DE DE602007009717T patent/DE602007009717D1/de active Active
- 2007-11-20 CN CN2007800431104A patent/CN101784268B/zh not_active Expired - Fee Related
- 2007-11-20 JP JP2009538405A patent/JP5542444B2/ja not_active Expired - Fee Related
- 2007-11-20 US US11/986,136 patent/US20080146556A1/en not_active Abandoned
- 2007-11-20 PT PT07862155T patent/PT2086525E/pt unknown
- 2007-11-20 NZ NZ595522A patent/NZ595522A/xx unknown
- 2007-11-20 MX MX2009005292A patent/MX2009005292A/es active IP Right Grant
- 2007-11-20 AT AT07862155T patent/ATE483456T1/de not_active IP Right Cessation
- 2007-11-20 TW TW096144000A patent/TWI519313B/zh not_active IP Right Cessation
- 2007-11-20 ES ES07862155T patent/ES2352817T3/es active Active
- 2007-11-20 AR ARP070105147A patent/AR063869A1/es unknown
- 2007-11-20 TW TW104129698A patent/TWI636795B/zh not_active IP Right Cessation
- 2007-11-20 CL CL200703331A patent/CL2007003331A1/es unknown
- 2007-11-20 AU AU2007321987A patent/AU2007321987B2/en not_active Ceased
- 2007-11-20 NZ NZ576693A patent/NZ576693A/en unknown
- 2007-11-20 EP EP07862155A patent/EP2086525B1/en not_active Not-in-force
2009
- 2009-05-03 IL IL198519A patent/IL198519A/en active IP Right Grant
2010
- 2010-02-04 HK HK10101210.0A patent/HK1137347A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
PT2086525E (pt)	2010-12-09
TW201601762A (zh)	2016-01-16
NZ576693A (en)	2011-12-22
MX2009005292A (es)	2009-08-13
US20080146556A1 (en)	2008-06-19
TW200829276A (en)	2008-07-16
IL198519A (en)	2014-07-31
AU2007321987A1 (en)	2008-05-29
CA2671517A1 (en)	2008-05-29
JP2010510312A (ja)	2010-04-02
CN101784268A (zh)	2010-07-21
AU2007321987B2 (en)	2014-01-23
CN101784268B (zh)	2013-06-19
ES2352817T3 (es)	2011-02-23
EP2086525A1 (en)	2009-08-12
TWI636795B (zh)	2018-10-01
TWI519313B (zh)	2016-02-01
ATE483456T1 (de)	2010-10-15
NZ595522A (en)	2013-04-26
JP5542444B2 (ja)	2014-07-09
EP2086525B1 (en)	2010-10-06
WO2008063644A1 (en)	2008-05-29
DE602007009717D1 (de)	2010-11-18
AR063869A1 (es)	2009-02-25
CA2671517C (en)	2015-01-27
HK1137347A1 (en)	2010-07-30
IL198519A0 (en)	2010-02-17

Similar Documents

Publication	Publication Date	Title
CL2007003331A1 (es)	2008-07-04	Metodo para tratar cancer mediante la administracion de un agente radiosensibilizante derivado de benzo[a]trinden-4,6-diona; composicion farmaceutica que comprende dicho agente.
BRPI0806531A2 (pt)	2014-04-22	Composto, composição farmacêutica, agente terapêutico, e, uso do composto.
BRPI0720546A2 (pt)	2015-06-23	Composto, inibidor, medicamento, agente antitumor, composição farmacêutica, método para tratar câncer, e, uso do composto
BRPI0922475A2 (pt)	2017-06-06	composto, composição farmacêutica , método para tratar câncer, e, uso de um composto.
BRPI0811317A2 (pt)	2015-01-27	Combinação, embalagem farmcêutica, kit ou mbalagem par apaciente, agente auxiliar, compsoto, usos de um agente auxiliar e de um composto, e, processo para a produção de uma combinação
CL2007003854A1 (es)	2008-05-30	Compuestos derivados de ciclopamina; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto, util en el tratamiento de desordenes mediados por la via de hedgehog, como cancer.
BRPI0814957A2 (pt)	2015-02-03	Composto, pró-droga, agente farmacêutico, método para a profilaxia ou tratamento de uma doença, distúrbio ou condição, e, uso do composto.
CL2007003226A1 (es)	2008-02-08	Compuestos derivados de piridinona; composicion farmaceutica; y uso para tratar el cancer.
BRPI0909768A2 (pt)	2015-10-06	composto, composição farmacêutica, método para o tratamento ou prevenção de uma doença ou distúrbio mediados pela ativação de b3-adrenoceptor, e, uso de um composto""composto, composição farmacêutica, método para o tratamento ou orevenção de uma doença ou distúrbio mediados pela ativação de b3-adrenoceptor, e, uso de um composto
CL2007003244A1 (es)	2008-04-04	Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
CL2007003356A1 (es)	2008-07-18	Compuestos derivados de benzopirazoles; proceso para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos y otro agente activo; y su uso para el tratamiento del asma, inflamacion, entre otras enfermedades.
BRPI0906576A2 (pt)	2015-07-07	Composição farmacêutica, kit, uso de um composto, e, agente terapêutico para câncer
BRPI0816881A2 (pt)	2015-03-17	Composto, composição farmacêutica, uso de um composto, e, métodos para tratar doenças ou distúrbios e para preparar um composto.
BRPI0912539A2 (pt)	2015-10-13	composto, composição farmacêutica , método para tratar uma doença, e, uso do composto.
CL2007003154A1 (es)	2008-05-09	Compuestos derivados de pirazolina; composicion farmaceutica que comprende a los compuestos; y uso para tratar afecciones cardiovasculares, renales, hepaticas y vasculares entre otras.
BRPI0815591A2 (pt)	2015-03-03	Composto, composição farmacêutica, uso de um composto, e, método para tratar uma doença, condição ou distúrbio.
DOP2007000043A (es)	2007-09-30	Derivados de cromanol sustituidos y su uso
IL197212A0 (en)	2009-12-24	Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent, and compositions containing the same
BR112012003464A2 (pt)	2015-09-08	composto, composição farmacêutica, usos de uma composição farmacêutica e de um composto, e, método para tratar uma doença ou um distúrbio."
BRPI0720169A2 (pt)	2013-12-24	Composto ou um sal do mesmo, prodroga, agente farmacêutico, método para a profilaxia ou tratamento de câncer, e, uso do composto
CL2007001838A1 (es)	2008-02-08	Compuestos derivados de 4-oxoquinolina; composicion farmaceutica; y uso del compuesto para la produccion de un agente anti-vih.
BR112012003280A2 (pt)	2017-05-23	composição farmacêutica para administração oral, método para tratar uma doença, uso do composto, e, composto.
DE502007005902D1 (de)	2011-01-20	-methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate
BRPI0818323A2 (pt)	2017-05-16	composição farmacêutica, uso de uma composição farmacêutica, e, método para tratar câncer.
CL2007003643A1 (es)	2008-03-24	Composicion farmaceutica de azimilidina que comprende 0,5% a aproximadamente 2,5% (w/w) de agua; y uso para el tratamiento de arritmias cardiacas.